These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2178380)

  • 21. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.
    Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J
    Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of non-Q-wave myocardial infarction: role of diltiazem versus beta-blocker therapy.
    Boden WE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S55-60. PubMed ID: 1707117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants and significance of diltiazem plasma concentrations after acute myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Nattel S; Talajic M; Goldstein RE; McCans J
    Am J Cardiol; 1990 Dec; 66(20):1422-8. PubMed ID: 2251986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary prevention with calcium antagonists after acute myocardial infarction.
    Hansen JF
    Drugs; 1992; 44 Suppl 1():33-43. PubMed ID: 1283582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Instantaneous cardiac death in the posthospital period after acute myocardial infarction.
    Sweeney MO; Moss AJ; Eberly S
    Am J Cardiol; 1992 Dec; 70(18):1375-9. PubMed ID: 1359781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.
    Liu L;
    Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group.
    Kornowski R; Goldbourt U; Zion M; Mandelzweig L; Kaplinsky E; Levo Y; Behar S
    Am J Cardiol; 1993 Oct; 72(12):883-8. PubMed ID: 8213543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS).
    Rengo F; Carbonin P; Pahor M; DeCaprio L; Bernabei R; Ferrara N; Carosella L; Acanfora D; Parlati S; Vitale D
    Am J Cardiol; 1996 Feb; 77(5):365-9. PubMed ID: 8602564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG
    Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
    Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J
    Am J Cardiol; 1999 Feb; 83(4):477-81. PubMed ID: 10073846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and significance of late evolution of Q waves in patients with initial non-Q-wave acute myocardial infarction. Diltiazem Reinfarction Study Group.
    Kleiger RE; Boden WE; Schechtman KB; Gibson RS; Schwartz DJ; Geiger BJ; Capone RJ; Roberts R
    Am J Cardiol; 1990 Jan; 65(1):23-7. PubMed ID: 2403730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diltiazem and mortality and reinfarction after myocardial infarction.
    N Engl J Med; 1989 Jan; 320(2):123-4. PubMed ID: 2911287
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study.
    Col NF; McLaughlin TJ; Soumerai SB; Hosmer DW; Yarzebski J; Gurwitz JH; Gore JM; Goldberg RJ
    Arch Intern Med; 1996 Jan; 156(1):54-60. PubMed ID: 8526697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.